innovation matters: the unintended consequences of drug pricing regulation
Published 2 years ago • 88 plays • Length 2:37Download video MP4
Download video MP3
Similar videos
-
47:13
james robinson - pricing drugs for innovation and affordability
-
1:25:05
demand asset pricing - ralph s. j. koijen
-
2:11
huge pressures on pricing in medical devices & pharmaceuticals
-
8:54
oiconomy pricing.
-
20:35
joost poort on policy considerations and the rationale for books price regulation
-
42:20
how pharmaceutical patents make drugs expensive
-
13:01
what i learned from parents who don't vaccinate their kids | jennifer reich | tedxmilehigh
-
1:35:40
human factors
-
0:59
competition and drug pricing
-
3:04
case study: discovery of pd-1 pathway biomarkers of target engagement
-
3:42
2022 consumer & market industry report: over-the-counter drug brands
-
1:28:24
webinar on revolutionizing healthcare: the transformative power of ai in medicine | engr. hina magsi
-
1:02:53
what drives drug pricing?
-
2:56
product development clinical safety: overview
-
3:07
drug pricing in focus as biopharma sector reports earnings
-
20:22
understanding regulatory components for drug and medical device innovations | march 4th, 2021
-
6:38
new clinical handbooks for adults and children | for psychiatrists & psychopharmacologists
-
2:19
pharmaceutical company to pay $10 million to cuyahoga, summit counties in opioid suit
-
6:28
comprehensive in silicon drug repositioning for covid-19 related proteins | ccs, univ. tsukuba
-
1:09
covalent inhibitor offers new therapeutic pathway in fight against covid-19
-
0:18
promation palletizer handling bags of flour